U.S. Department of Health & Human Services

NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Recently Added Within 3 Months Remove constraint Recently Added: Within 3 Months Subjects Humans Remove constraint Subjects: Humans
Number of results to display per page

Search Results

51. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices

nlm:nlmuid-101744770-pdf

53. Aligning services with needs: characterizing the pyramid of complexity tiering for children with chronic and complex conditions

nlm:nlmuid-101744810-pdf

56. Threading the labyrinth: why children in California with special health care needs endure delays in securing the medical equipment and supplies they need

nlm:nlmuid-101744823-pdf

58. Achieving care integration for children with medical complexity: the human-centered design approach to care coordination

nlm:nlmuid-101744833-pdf

61. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report

nlm:nlmuid-101744949-pdf

62. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

nlm:nlmuid-101744954-pdf

65. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report

nlm:nlmuid-101744957-pdf

67. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

nlm:nlmuid-101745013-pdf

68. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

nlm:nlmuid-101745015-pdf

70. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report

nlm:nlmuid-101745056-pdf

71. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

nlm:nlmuid-101745061-pdf

72. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

nlm:nlmuid-101745064-pdf

73. Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states

nlm:nlmuid-101745975-pdf

74. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Arizona

nlm:nlmuid-101745986-pdf

75. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Colorado

nlm:nlmuid-101746005-pdf

76. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Florida

nlm:nlmuid-101746013-pdf

77. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Idaho

nlm:nlmuid-101746022-pdf

78. Medicaid eligibility, enrollment, and renewal processes and system study: case study summary report--New York

nlm:nlmuid-101746024-pdf

79. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--North Carolina

nlm:nlmuid-101746028-pdf

80. Leveraging 1332 state innovation waivers to stabilize individual health insurance markets: experiences of Alaska, Minnesota, and Oregon : final report : document efforts to stabilize the individual market using state-based reinsurance

nlm:nlmuid-101746041-pdf

81. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

nlm:nlmuid-101746066-pdf

82. Low-wage workers: poverty and use of selected federal social safety net programs persist among working families : report to the ranking member, Subcommittee on Primary Health and Retirement Security, Committee on Health, Education, Labor, and Pensions, U.S. Senate

nlm:nlmuid-101746075-pdf

84. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

nlm:nlmuid-101746113-pdf

85. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

nlm:nlmuid-101746114-pdf

86. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives

nlm:nlmuid-101746120-pdf

87. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives

nlm:nlmuid-101746124-pdf

88. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

nlm:nlmuid-101746126-pdf

89. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives

nlm:nlmuid-101746132-pdf

90. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

nlm:nlmuid-101746137-pdf

91. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress

nlm:nlmuid-101746148-pdf

94. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives

nlm:nlmuid-101746193-pdf

95. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

nlm:nlmuid-101746203-pdf

96. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters

nlm:nlmuid-101746210-pdf

99. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

nlm:nlmuid-101746249-pdf

100. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees

nlm:nlmuid-101746254-pdf